Prioritization of biomarker targets in human umbilical cord blood: Identification of proteins in infant blood serving as validated biomarkers in adults

Environmental Health Perspectives

Volumn 120, Issue 5, 2012, Pages 764-769

  Hansmeier, Nicole ^a   Chao, Tzu Chiao ^a   Goldman, Lynn R ^b   Witter, Frank R ^c   Halden, Rolf U ^a,d  

^a ARIZONA STATE UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Body fluid; Diagnostics; Disease; LC MALDI MS; Pathways; Proteomics

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN; PROTEOME;

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; ISOELECTRIC FOCUSING; MALE; METABOLISM; NEWBORN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD;

EID: 84861073971     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104190     Document Type: Article

References (78)

1. Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
2. Ahrens CH, Brunner E, Qeli E, Basler K, Aebersold R. 2010a. Generating and navigating proteome maps using mass spectrometry. Nat Rev Mol Cell Biol 11:789-801.
3. Ahrens CH, Schrimpf SP, Brunner E, Aebersold R. 2010b. Model organism proteomics. J Proteomics 73:2051-2053.
4. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, et al. 2002. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1:947-955.
5. Anderson NL. 2010. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 56:177-185.
6. Aoki-Kinoshita KF, Kanehisa M. 2007. Gene annotation and pathway mapping in KEGG. Methods Mol Biol 396:71-91.
7. Apelberg BJ, Goldman LR, Calafat AM, Herbstman JB, Kuklenyik Z, Heidler J, et al. 2007a. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41:3891-3897.
8. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007b. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670-1676.
9. Barker DJP, Eriksson JG, Forsén T, Osmond C. 2002. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31:1235-1239.
10. Beck M, Claassen M, Aebersold R. 2011. Comprehensive proteomics. Curr Opin Biotechnol 22:3-8.
11. Bell AW, Deutsch EW, Au CE, Kearney RE, Beavis R, Sechi S, et al. 2009. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat Methods 6:423-430.
12. Benkusky NA, Weber CS, Scherman JA, Farrell EF, Hacker TA, John MC, et al. 2007. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ Res 101:819-829.
13. Betzenhauser MJ, Marks AR. 2010. Ryanodine receptor channelopathies. Pflugers Arch 460:467-480.
14. Biscetti F, Straface G, Pitocco D, Zaccardi F, Ghirlanda G, Flex A. 2009. Peroxisome proliferator-activated receptors and angiogenesis. Nutr Metab Cardiovasc Dis 19:751-759.
15. Bloomgarden ZT. 2004. Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 27:998-1010.
16. Buchheiser A, Liedtke S, Looijenga LHJ, Kögler G. 2009. Cord blood for tissue regeneration. J Cell Biochem 108:762-768.
17. Buczyníska A, Tarkowski S. 2005. Environmental exposure and birth outcomes. Int J Occup Med Environ Health 18:225-232.
18. Bulhak AA, Jung C, Ostenson C, Lundberg JO, Sjöquist P, Pernow J. 2009. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol 296:H719-H727.
19. Carr S, Aebersold R, Baldwin M, Burlingame A, Clauser K, Nesvizhskii A. 2004. The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol Cell Proteomics 3:531-533.
20. Chan KC, Lucas DA, Hise D, Schaefer CF, Xiao Z, Janini GM, et al. 2004. Analysis of the human serum proteome. Clin Proteomics 1:101-226.
21. Chao TC, Hansmeier N, Halden RU. 2010. Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery. J Proteomics 73:1641-1646.
22. Chou WC, Chen JL, Lin CF, Chen YC, Shih FC, Chuang CY. 2011. Biomonitoring of bisphenol A concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in Taiwan. Environ Health 10:94; doi:10.1186/1476-069X-10-94 [Online 3 November 2011].
23. Colquhoun DR, Goldman LR, Cole RN, Gucek M, Mansharamani M, Witter FR, et al. 2009. Global screening of human cord blood proteomes for biomarkers of toxic exposure and effect. Environ Health Perspect 117:832-838.
24. Craig WY, Palomaki GE, Haddow JE. 1989. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 298:784-788.
25. Domon B, Aebersold R. 2010. Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechol 28:710-721.
26. Donelan W, Koya V, Li SW, Yang, LJ. 2010. Distinct regulation of hepatic nuclear factor 1 by NKX6.1 in pancreatic beta cells. J Biol Chem 285:12181-12189.
27. Durham WJ, Wehrens XHT, Sood S, Hamilton SL. 2007. Diseases associated with altered ryanodine receptor activity. Subcell Biochem 45:273-321.
28. Ehmann M, Felix K, Hartmann D, Schnölzer M, Nees M, Vorderwülbecke S, et al. 2007. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34:205-214.
29. El Far M, El Naggar M, Elkhawaga OA, Yahya R, Allam A, Khalifa A. 2006. Carcinoembryonic antigen, alpha-fetoprotein, and prostate-specific antigen in the sera of industrial workers exposed to phenol, formaldehyde, urea, and mixed vapors. Inhal Toxicol 18:1041-1046.
30. Elias JE, Haas W, Faherty BK, Gygi SP. 2005. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat Methods 2:667-675.
31. Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, et al. 2011. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics; doi:10.1074/mcp.M110.006353 [Online 1 June 2011].
32. Ferrara A. 2007. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30:S141-S146.
33. Forraz N, McGuckin CP. 2011. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif 44:60-69.
34. Gaso-Sokac D, Josic D, 2010. The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins. Blood Transfus 8:s86-s91.
35. Georgieff MK, Chockalingam UM, Sasanow SR, Gunter EW, Murphy E, Ophoven JJ. 1988. The effect of antenatal betamethasone on cord blood concentrations of retinol-binding protein, transthyretin, transferrin, retinol, and vitamin E. J Pediatr Gastroenterol Nutr 7:713-717.
36. Götz S, García-Gómez JM, Terol J, Williams TD, Nagaraj SH, Nueda MJ, et al. 2008. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res 36:3420-3435.
37. Graham A. 2002. Jaw development: chinless wonders. Curr Biol 12:R810-R812.
38. Guerrero-Preston R, Goldman LR, Brebi-Mievielle P, Ili-Gangas C, Lebron C, Witter FR, et al. 2010. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 16:539-546.
39. Hansmeier N, Chao TC, Goldman LR, Witter FR, Halden RU. 2012. Appendix 1-4 and MS data files. Prioritization of biomarker targets in human umbilical cord blood: identification of proteins in infant blood serving as validated biomarkers in adults. Publication 2012. Tempe, AZ:Biodesign Institute, Arizona State University. Available: http://labs.biodesign.asu.edu/halden/publications/ [accessed 23 January 2012].
40. Herbstman JB, Sjödin A, Apelberg BJ, Witter FR, Patterson DG, Halden RU, et al. 2007. Determinants of prenatal exposure to polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) in an urban population. Environ Health Perspect 115:1794-1800.
41. Health Insurance Portability and Accountability Act (HIPAA). 2002. Standards for Privacy of Individually Identifiable Health Information; Final Rule. 45 CFR Parts 160, 164.
42. Hughes GJ, Frutiger S, Paquet N, Ravier F, Pasquali C, Sanchez JC, et al. 1992. Plasma protein map: an update by microsequencing. Electrophoresis 13:707-714.
43. Karamessinis PM, Malamitsi-Puchner A, Boutsikou T, Makridakis M, Vougas K, Fountoulakis M, et al. 2008. Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications. Mol Cell Proteomics 7:591-599.
44. Karmaus W, Brooks KR, Nebe T, Witten J, Obi-Osius N, Kruse H. 2005. Immune function biomarkers in children exposed to lead and organochlorine compounds: a cross-sectional study. Environ Health 4:5; doi:10.1186/1476-069X-4-5 [Online 14 April 2005].
45. Langrish JP, Lundbäck M, Mills NL, Johnston NR, Webb DJ, Sandström T, et al. 2009. Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans. Hypertension 54:910-915.
46. Lemos MFL, Soares AMVM, Correia AC, Esteves AC. 2010. Proteins in ecotoxicology - how, why and why not? Proteomics 10:873-887.
47. Liumbruno G, D'Alessandro A, Grazzini G, Zolla L. 2010. Blood-related proteomics. J Proteomics 73(3):483-507.
48. Mantzoros CS, Rifas-Shiman SL, Williams CJ, Fargnoli JL, Kelesidis T, Gillman MW. 2009. Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study. Pediatrics 123:682-689.
49. Mattison DR. 2010. Environmental exposures and development. Curr Opin Pediatr 22:208-218.
50. Miranda ML, Maxson P, Edwards S. 2009. Environmental contributions to disparities in pregnancy outcomes. Epidemiol Rev 31:67-83.
51. Morley SL. 2011. Management of acquired coagulopathy in acute paediatrics. Arch Dis Child Educ Pract Ed 96:49-60.
52. Neta G, Goldman LR, Barr D, Apelberg BJ, Witter FR, Halden RU. 2011. Fetal exposure to chlordane and permethrin mixtures in relation to inflammatory cytokines and birth outcomes. Environ Sci Technol [Epub ahead of print].
53. Nilsson T, Mann M, Aebersold R, Yates JR, Bairoch A, Bergeron JJM. 2010. Mass spectrometry in high-throughput proteomics: ready for the big time. Nat Methods 7:681-685.
54. Notarangelo LD. 2010. Primary immunodeficiencies. J Allergy Clin Immunol 125:S182-S194.
55. Nyland JF, Wang SB, Shirley DL, Santos EO, Ventura AM, de Souza JM, et al. 2011. Fetal and maternal immune responses to methylmercury exposure: a cross-sectional study. Environ Res 111:584-589.
56. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. 2005. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core data set of 3020 proteins and a publicly-available database. Proteomics 5:3226-3245.
57. Parker H, An Q, Barber K, Case M, Davies T, Konn Z, et al. 2008. The complex genomic profile of positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. Genes Chromosomes Cancer 47:1118-1125.
58. Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, et al. 2008. Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ Health Perspect 116:937-942.
59. Pieper R, Su Q, Gatlin CL, Huang S, Anderson NL, Steiner S. 2003. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3:422-432.
60. ProteomeCommons.org. 2012. UCB Proteome. Available: https://proteomecommons.org/group.jsp?i=320 [accessed 12 February 2012].
61. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. 2005. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5:3262-3277.
62. Reiter L, Claassen M, Schrimpf SP, Jovanovic M, Schmidt A, Buhmann JM, et al. 2009. Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry. Mol Cell Proteomics 8:2405-2417.
63. Richter R, Schulz-Knappe P, Schrader M, Ständker L, Jürgens M, Tammen H, et al. 1999. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B Biomed Sci Appl 726:25-35.
64. Rydjord B, Eduard W, Stensby B, Sandven P, Michaelsen TE, Wiker HG. 2007. Antibody response to long-term and high-dose mould-exposed sawmill workers. Scand J Immunol 66:711-718.
65. Schenk S, Schoenhals GJ, de Souza G, Mann M. 2008. A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 1:e41; doi:10.1186/1755-8794-1-41 [Online 15 September 2008].
66. Semba K, Araki K, Li Z, Matsumoto K, Suzuki M, Nakagata N, et al. 2006. A novel murine gene, Sickle tail, linked to the Danforth's short tail locus, is required for normal development of the intervertebral disc. Genetics 172:445-456.
67. Shi L, Zhang J, Wu P, Feng K, Li J, Xie Z, et al. 2009. Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia. Proteome Sci 7:7; doi:10.1186/1477-5956-7-7 [Online 16 March 2009].
68. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, et al. 2007. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6:1638-1655.
69. Song H, Zhang P, Guo X, Liao L, Zhou Z, Sha J, et al. 2009. The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry. Acta Pharmacol Sin 30:1550-1558.
70. States DJ, Omenn GS, Blackwell TW, Fermin D, Eng J, Speicher DW, et al. 2006. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 24:333-338.
71. Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H. 2009. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1920-1924.
72. Través C, Coll O, Cararach V, Gual A, de Tejada BM, López-Tejero MD. 2007. Clinical approach to intestinal maturation in neonates prenatally exposed to alcohol. Alcohol 42:407-412.
73. Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, Billingham LJ, et al. 2006. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 94:1898-1905.
74. Wehrens XHT, Marks AR. 2003. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends Biochem Sci 28:671-678.
75. Wells EM, Jarrett JM, Hong LY, Caldwell KL, Hibbeln JR, Apelberg BJ, et al. 2011. Body burdens of mercury, lead, selenium and copper among Baltimore newborns. Environ Res 111:411-417.
76. Wigle DT, Arbuckle TE, Walker M, Wade MG, Liu S, Krewski D. 2007. Environmental hazards: evidence for effects on child health. J Toxicol Environ Health B Crit Rev 10:3-39.
77. Witter FR, Ten Broeck J, Fox HE. 2001. A new device for safer collection of postpartum cord blood. Int J Gynaecol Obstet 72:259-260.
78. Xu D, Allsop SA, Witherspoon SM, Snider JL, Yeh JJ, Fiordalisi JJ, et al. 2011. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells. Carcinogenesis 32:488-495.